Abstract Details

Title Plasmapheresis Enables Robust Micro-Dystrophin Expression Following Gene Transfer in Subjects with Pre-Existing Immunity

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) (-)

Poster/Presentation
Number 016

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Louis Chicoine PRESENTER	No disclosure on file
Roshan L. Koul, MD, DM, FRCPCH (Sultan Qaboos University Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
Danielle A. Griffin	Ms. Griffin has stock in Sarepta Therapeutics. Ms. Griffin has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
K. Reed Clark, PhD	No disclosure on file
Zarife F. Sahenk, MD, PhD, FAAN (The Research Institute at Nationwide Childrens.org)	Dr. Sahenk has nothing to disclose.
Christopher Walker, PhD (The Research Institute)	No disclosure on file
Jerry R. Mendell, MD, FAAN (The Research Institute at Nationwide Children's Hospital)	Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Louise R. Rodino-Klapac (Sarepta Therapeutics)	Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��